Navigation Links
Middle East to be the Future in Clincial Trials
Date:8/17/2011

DUBAI, UAE, August 17, 2011 /PRNewswire/ --

Global pharmaceutical companies are currently seeking emerging markets to conduct clinical trials due to the increase in drug development costs and the demand to advance drugs faster.

The Middle East is forecasted to be one of the fastest growing markets for clinical research outsourcing based on availability of the required infrastructure, access to necessary patients, faster timelines and lower costs compared to other markets.

Clinical Trials Partnership Middle East Summit will assemble all stakeholders from leading research sites, clinical research organisations, regulators, government organisations and pharmaceutical companies to provide strategies and knowledge on critical issues such as regulatory compliance, optimising clinical trials, overcoming clinical trials challenges and identifying business opportunities in the Middle East region.

Taking place between 28th & 30th November 2011 in Dubai, this three day summit is a must for all executives, senior level directors or directors from the pharmaceutical, biotech, clinical research organisations and clinical investigators who are looking to discuss the advances of the regions clinical trials market.

Clinical Trails Partnership Middle East Summit kicks off with an essential interactive workshop on day one, looking at a comprehensive overview of 'Good Clinical Practice' in relation to the regional and international guidelines for conducting clinical trials.

The next two days are packed full of exciting and innovative discussions, crucial networking opportunities and exciting round table discussions where delegates will be able to share their views and knowledge on subjects such as 'Improving the quality of clinical trials by using standardised performance metrics'.

Event Director for Clinical Trails Partnership Middle East Summit, DoaaSaid, described the conference as'A vital event for the increasing success and on-going improvement and competitiveness of the regions clinical trials market.'

Delegates in the field will come away from the summit with all the tools needed to better their practices, making them more competitive and efficient. They will also have the chance to make vital relationships and connections in the scheduled networking periods.

Registration for this event is now open on the website http://www.clinicaltrialsmena.com. Delegates booking before 19th September 2011 will receive a discount of up to $450.

For more information about the Clinical Trails Partnership Middle East Summit please contact Jihan Mohammed, Marketing Manager, IQPC Middle East, Email enquiry@iqpc.ae or call +971-364-2975


'/>"/>
SOURCE IQPC Middle East
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioElectronics Corp Aggressively Expands Sales into Middle East
2. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
3. MiddleBrook Hires TalenTactics to Recruit National Field Force
4. Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP
5. MiddleBrook Pharmaceuticals Hires Key Commercial Team Members
6. CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East
7. Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference
8. Leading Middle East Cancer Hospital Acquires Advanced Radiotherapy Capability from Varian Medical Systems
9. NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region
10. Misonix Announces New Sales Agency Agreement for Middle East, India and Pakistan
11. Microbix Signs Marketing Agreement For Kinlytic(R)(Urokinase) In Growing Middle East Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- GlobeImmune, Inc. today announced it has entered into a ... of its common stock to NantCell, Inc., a member ... sale of its common stock, NantCell has agreed to ... 200,000 shares, an estimated $2.0 million in value, of ... to enter into this strategic agreement with NantCell," said ...
(Date:3/23/2017)... York , March 23, 2017 According ... plasma products and derivatives market is fragmented due to the presence of ... such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with ... these three companies, collectively, held more than 76% of this market ... As ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a ... lab samples to full-size tissues, bones, even whole organs to implant in people ... delivers blood deep into the developing tissue. , Current bioengineering techniques, including ...
(Date:3/22/2017)... 2017   iSpecimen ®, the marketplace ... Pathology Service (DPS), a full-service anatomic pathology reference ... United States , has joined a program offered ... (DHIN) to make human biospecimens and associated data ... program, announced in 2015 as a collaboration between iSpecimen ...
Breaking Biology Technology:
(Date:3/1/2017)... BEDFORD, Mass. , March 1, 2017  Aware, ... and services, announced that Richard P. Moberg ... Officer and co-President and Chief Financial Officer and Treasurer ... will continue to serve as a member of the ... T. Russell , Aware,s co-Chief Executive Officer and co-President, ...
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber Ventures ... it has led a $3.5 million investment in  Polarity ... Strategic Cyber Ventures is DC based and is led ... Hank Thomas . Ron Gula , also a ... also participated in this series A round of funding. ...
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
Breaking Biology News(10 mins):